Showing results (1-10 of 283) with videos related to
Sort By:
Pageof 29
Nihon Rinsho. Japanese Journal of Clinical Medicine|March 14, 2015
[Direct-acting antiviral-resistant variant]Michio Imamura, Kazuaki ChayamaNihon Rinsho. Japanese Journal of Clinical Medicine|July 15, 2006
[HCV-HBV infection]Michio Imamura, Kazuaki ChayamaHepatology Research : the Official Journal of the Japan Society of Hepatology|April 25, 2012
Impact of interleukin-28B genotype on in vitro and in vivo systems of hepatitis C virus replicationKazuaki Chayama, C Nelson Hayes, Michio ImamuraExpert Review of Gastroenterology & Hepatology|December 13, 2016
The practical management of chronic hepatitis C infection in Japan - dual therapy of daclatasvir + asunaprevirC Nelson Hayes, Michio Imamura, Kazuaki ChayamaExpert Review of Gastroenterology & Hepatology|August 9, 2019
Management of HCV patients in cases of direct-acting antiviral failureC Nelson Hayes, Michio Imamura, Kazuaki ChayamaJournal of UOEH|July 13, 2004
Pitavastatin enhances the anti-fibrogenesis effects of candesartan, an angiotensin II receptor blocker, on CCl4-induced liver fibrosis in ratsLianbo Nie, Michio Imamura, Hideaki Itoh, et al.Liver International : Official Journal of the International Association for the Study of the Liver|December 30, 2021
Road to elimination of HCV: Clinical challenges in HCV managementC Nelson Hayes, Michio Imamura, Junko Tanaka, et al.Nature Reviews. Gastroenterology & Hepatology|May 30, 2012
Genetics of IL28B and HCV--response to infection and treatmentC Nelson Hayes, Michio Imamura, Hiroshi Aikata, et al.Gastroenterology|January 6, 2005
Suppression of macrophage infiltration inhibits activation of hepatic stellate cells and liver fibrogenesis in ratsMichio Imamura, Tadashi Ogawa, Yasuyuki Sasaguri, et al.Human Immunology|October 11, 2014
Impact of alloimmune T cell responses on hepatitis C virus replication in liver transplant recipientsYuka Tanaka, Masahiro Ohira, Hirotaka Tashiro, et al.Pageof 29